Sage Therapeutics Inc SAGE
NAS: SAGE | ISIN: US78667J1088 3/07/2025
9,200 USD (+1,32%)
(+1,32%)
3/07/2025
Profiel Sage Therapeutics Inc
Website: www.sagerx.com
Hoofdzetel: Cambridge, Massachusetts Verenigde Staten
CEO: Jeffrey Jonas
Werknemers: 780